Pamela J Goodwin

9PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineTe hauora me te oranga ā-whaea, ā-pēpi o te Māori (Māori mothers and babies health and wellbeing)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32.

|Sep 11, 2023
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.

Pamela J Goodwin, Bingshu E Chen, Karen A Gelmon

|Apr 04, 2022
The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor-Positive Breast Cancer.

Ana Elisa Lohmann, Marguerite Ennis, Wendy R Parulekar

|Sep 06, 2021
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo.

Pamela J Goodwin, Ryan J O Dowling, Marguerite Ennis

|Jul 23, 2021
Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis.

Martin C Chang, Zohreh Eslami, Marguerite Ennis

|Jun 09, 2021
Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial.

Pamela J Goodwin, Ryan J O Dowling, Marguerite Ennis

Pageof 2

Frequent Collaborators

5 joint publications

Marguerite Ennis

4 joint publications

Bingshu E Chen

3 joint publications

Dawn L Hershman

2 joint publications

Kathleen I Pritchard